FAQ

ENA 713

Known as: ENA713, ENA-713, ENA 713, SDZ 
 

Topic mentions per year

Topic mentions per year

1993-2005
02419932005

Related topics

Related topics

2 relations
Rivastigmine tartraterivastigmine

Related mentions per year

Related mentions per year

1971-2018
197019801990200020102020
ENA 713
rivastigmine
Rivastigmine tartrate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
In vivo neurochemical effects of the acetylcholinesterase inhibitor ENA713 in rat hippocampus.
Oral ENA713 (0.5, 1.5 and 4.5 mg/kg), an acetylcholinesterase inhibitor (AChEI), dose-dependently enhanced extracellular… (More)
Is this relevant?
1999
1999
The acetylcholinesterase inhibitor, ENA 713 (Exelon), attenuates the working memory impairment induced by scopolamine in an operant DNMTP task in rats
  Rationale: The disruption of working memory in the delayed non-matching to position (DNMTP) task by the muscarinic antagonist… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
1999
1999
Effect of donepezil hydrochloride (E2020) on basal concentration of extracellular acetylcholine in the hippocampus of rats.
The effects of oral administration of the centrally acting acetylcholinesterase (AChE) inhibitors, donepezil hydrochloride… (More)
Is this relevant?
1999
1999
Preferential cerebrospinal fluid acetylcholinesterase inhibition by rivastigmine in humans.
This study sought to examine the feasibility of prolonged assessment of acetylcholinesterase (AChE) activity in the cerebrospinal… (More)
Is this relevant?
1998
1998
Absorption, Metabolism, and Disposition of [14C]SDZ ENA 713, an Acetylcholinesterase Inhibitor, in Minipigs Following Oral, Intravenous, and Dermal Administration
Purpose. SDZ ENA 713 (rivastigmine) is an acetylcholinesterase inhibitor intended for therapeutic use in Alzheimer's disease. The… (More)
Is this relevant?
1998
1998
Cerebro-protective effects of ENA713, a novel acetylcholinesterase inhibitor, in closed head injury in the rat.
Focal ischemic brain damage and diffuse brain swelling occur in severe cases of traumatic head injury. Ischemia decreases brain… (More)
Is this relevant?
1996
1996
Safety/tolerability trial of SDZ ENA 713 in patients with probable Alzheimer's disease.
SDZ ENA 713 (ENA 713) is an acetylcholinesterase inhibitor being developed as a potential treatment for Alzheimer's disease (AD… (More)
Is this relevant?
1995
1995
Post-ischemic administration of the acetylcholinesterase inhibitor ENA-713 prevents delayed neuronal death in the gerbil hippocampus
We examined by morphological methodology the effect of (S)-N-ethyl-3-[(1-dimethyl-amino)ethyl]-N-methyl-phenylcarbamate… (More)
  • figure 1
  • table I
  • figure 2
  • table II
Is this relevant?
1994
1994
Acetylcholinesterase inhibitor ENA-713 protects against ischemia-induced decrease in pre- and postsynaptic cholinergic indices in the gerbil brain following transient ischemia
The effects of pre-treatment with ENA-713, an acetylcholinesterase (AChE) inhibitor, on changes in pre- and postsynaptic… (More)
  • figure 2
  • figure 1
  • table I
  • figure 3
  • figure 4
Is this relevant?
1993
1993
Effects of the acetylcholinesterase inhibitor ENA-713 on ischemia-induced changes in acetylcholine and aromatic amine levels in the gerbil brain.
The effects of a new acetylcholinesterase inhibitor, ENA-713, on ischemia-induced changes in acetylcholine, monoamines, and their… (More)
Is this relevant?